CytomX Therapeutics Inc Cash Flow Reinvestment Rate
CytomX Therapeutics Inc cash flow reinvestment rate. CytomX Therapeutics Inc (CTMX) has a Cash Flow Reinvestment Rate of 15.69x as of March 2023, reinvesting $146.64 Million (capex $48.00K plus investments $-146.59 Million) from operating cash flow of $9.35 Million. Explore CTMX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of CytomX Therapeutics Inc (2014–2020)
Cash flow reinvestment rate of CytomX Therapeutics Inc from 2014 to 2020. Historical reinvestment intensity for CytomX Therapeutics Inc across 3 annual periods. Explore CytomX Therapeutics Inc (CTMX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
CytomX Therapeutics Inc Cash Flow Reinvestment Rate by Year (2014–2020)
CytomX Therapeutics Inc cash flow reinvestment rate by year from 2014 to 2020. Year-by-year capital reinvestment analysis for CytomX Therapeutics Inc. For the full cash flow conversion analysis, see CytomX Therapeutics Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 3.56x | $18.72 Million | $5.26 Million | $2.31 Million | ▲ +393.7% |
| 2017 | 0.72x | $122.83 Million | $170.37 Million | $1.56 Million | ▼ -82.3% |
| 2014 | 4.08x | $129.81 Million | $31.80 Million | $1.66 Million | — |